The Agency for Business & Economic Development (AWE), together with SAVax, a programme commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), implemented by GIZ in cooperation with South Africa’s Department of Science, Technology and Innovation and Department of Health, invites you to an interactive online webinar on opportunities for European companies in the pharmaceutical and biotechnology sectors in South Africa.
As South Africa scales up local production of pharmaceuticals, vaccines, and health technologies, new opportunities are emerging for European companies to collaborate, invest, and innovate. The webinar will bring together innovation accelerators, grantees and innovators, and private sector stakeholders from Germany, the EU, and South Africa to explore concrete entry points for cooperation.
What to expect:
- Insights into South Africa’s biopharmaceutical and biotech ecosystem, including infrastructure, policy frameworks, and market potential
- Opportunities for European engagement, from contract manufacturing and licensing to R&D and technology transfer
- Presentations from leading South African accelerators and innovation platforms, showcasing high-potential products and enterprises
- Discussion on implementation modalities such as technical assistance, grants, and training support
- Next steps for collaboration including matchmaking with local partners and project support through GIZ/SAVax
Target audience:
- European and German companies active in pharmaceuticals, biotech, health tech, and related services
- Innovation accelerators and grantees
- Investors and support organizations interested in international collaboration
- Discover how your company can engage in South Africa’s dynamic health innovation ecosystem, with the support of SAVax and its partners.
More details about the preliminary agenda can be found here.
You can register for the webinar here.